VIRTUS FUND ADVISERS, LLC Halozyme Therapeutics, Inc. Transaction History

VIRTUS FUND ADVISERS, LLC portfolio value:

$0
portfolio value

VIRTUS FUND ADVISERS, LLC quarter portfolio value change:

+95.16%
quarter

Halozyme Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -100.00% -48.40K shares -981K $39.54 0
Q4 2017 share Increase 0.00% 48.40K shares 981K $20.26 48.40K